SOX2 and neoplasm: VDAC1-based peptide tumor treatment eliminated GSCs, as reflected in the marked decrease in the expression levels of all tested stem cell markers, namely Sox2, Nestin, CD133, Klf4, S100B and NGFR (Figure 6).